Skip to main content
PYPD logo

PolyPid Ltd.

PYPDNASDAQHealthcareBiotechnology

$4.90Today:- (-)1Y +46.27%

As of Oct 15, 2026 close

Market cap
$110.92M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.10$5.73
Volume (live)
-
Avg. volume (3M)
91.17K

PolyPid (PYPD) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), PolyPid used $27.88M of cash in operating activities and spent $210.00K on capital expenditures. That left free cash flow of −$28.09M.

PolyPid Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for PolyPid Ltd. (PYPD) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-34.17-29.02-23.87-39.56-42.60-36.87-6.915.92-54.49
Depreciation & Amortization1.461.621.821.721.121.010.950.410.21
Stock Based Compensation4.852.823.394.314.750.000.000.000.00
Change in Working Capital0.361.92-0.11-1.084.35-1.69-1.010.47-0.19
Change in Accounts Receivable0.000.000.000.000.12-1.920.000.000.00
Change in Inventory-1.110.000.000.000.000.000.000.000.00
Change in Accounts Payable0.181.64-0.37-3.102.22-0.610.000.000.00
Change in Other Working Capital-0.89-0.211.730.890.080.84-1.010.47-0.19
Other Operating Activities-0.890.701.730.294.7515.95-10.39-23.4842.16
Net Cash from Operating Activities-27.88-21.96-17.24-34.32-32.39-21.60-17.36-16.68-12.31
Investing Activities
Capital Expenditures-0.21-0.08-0.20-1.77-2.99-1.18-0.88-3.07-1.88
Purchases of Investments-26.22-21.35-18.60-7.00-8.00-39.59-22.690.00-6.50
Sales/Maturities of Investments19.7221.1022.6025.3447.890.000.0014.030.00
Net Cash from Investing Activities-6.70-0.333.8016.5836.90-40.77-23.5610.96-8.39
Financing Activities
Debt Repayment-6.38-3.32-2.62-0.400.000.000.000.000.00
Common Stock Issued32.6035.8612.715.121.0362.7737.659.3914.38
Other Financing Activities-0.86-3.02-0.130.370.000.000.009.3614.32
Net Cash from Financing Activities25.3732.429.9816.431.0362.7737.659.3914.38
Summary
Effect of Forex Changes on Cash-9.210.080.000.16-0.040.000.02-0.030.00
Net Change in Cash-9.2110.12-3.46-1.315.550.41-3.253.64-6.31
Cash at Beginning of Period15.815.619.1410.464.714.307.553.9110.22
Cash at End of Period6.6015.815.699.1410.224.714.307.553.91
Free Cash Flow-28.09-22.04-17.43-36.08-35.38-22.77-18.24-19.75-14.20
Supplemental Disclosures
Interest Paid-0.951.040.73-----
Income Taxes Paid-0.000.020.01-----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About PolyPid Cash Flow

What is PolyPid's free cash flow?

PolyPid had negative free cash flow of $28.09M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$27.88M minus $210.00K of capital expenditures.

How much does PolyPid spend on capital expenditures?

PolyPid spent $210.00K on capital expenditures in fiscal 2025, compared with $76.00K a year earlier.

Does PolyPid pay dividends or buy back shares?

PolyPid's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition